4.5 Letter

Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?

Journal

BREAST CANCER RESEARCH AND TREATMENT
Volume 114, Issue 2, Pages 387-389

Publisher

SPRINGER
DOI: 10.1007/s10549-008-0015-4

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available